Mercer Global Advisors Inc Rallybio Corp Transaction History

Mercer Global Advisors Inc

  • $45.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.25 - $2.4 $12,500 - $24,000
10,000 New
10,000 $19,000
Q1 2023

May 15, 2023
BUY
$4.37 - $8.75 $43,700 - $87,500
10,000 New
10,000 $57,000
Q2 2022

Aug 10, 2022
BUY
$6.26 - $13.65 $62,600 - $136,500
10,000 New
10,000 $76,000

Others Institutions Holding RLYB

# of Institutions
52
Shares Held
31.9M
Call Options Held
0
Put Options Held
0
View Full List

About Rallybio Corp

RLYB Quotes by TradingView
  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $30.5M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email